戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ve sleep apnoea (OSA), which is a widespread respiratory disorder.
2 ology of this syndrome, and may underlie the respiratory disorder.
3 t, and 13.9% had a hospital admission, for a respiratory disorder.
4 nd prevention of cardiovascular diseases and respiratory disorders.
5 ial therapeutic targets for treating central respiratory disorders.
6 ion may also be mechanistically important in respiratory disorders.
7 y stages of both obstructive and restrictive respiratory disorders.
8 ieving therapeutic cAMP elevation in chronic respiratory disorders.
9 llitus and neurological, rheumatological and respiratory disorders.
10 er environmental factors, is a new entity in respiratory disorders.
11 x specific and highly heterogeneous group of respiratory disorders.
12 cturally analogous drugs and a wide array of respiratory disorders.
13  challenging task of diagnosing and treating respiratory disorders.
14 nal disorders, and eight (26%) patients with respiratory disorders.
15 tory distress syndrome, are life-threatening respiratory disorders.
16 icant information to identify the main acute respiratory disorders.
17  for the treatment of immune, oncogenic, and respiratory disorders.
18 re also present in several critical neonatal respiratory disorders.
19 h as those provoked by ear, nose, throat, or respiratory disorders.
20  microbiome have been recognized in multiple respiratory disorders.
21 d with increased risk for cardiovascular and respiratory disorders.
22 erapeutic tool for the management of several respiratory disorders.
23 ymptoms of ILD often overlap those of common respiratory disorders.
24 effusion in patients with different baseline respiratory disorders.
25 OSA) and asthma are highly prevalent chronic respiratory disorders.
26         Activin-A is up-regulated in various respiratory disorders.
27 targets for the treatment of a wide range of respiratory disorders.
28 clinical use of 5-HT1A agonists for post-SCI respiratory disorders.
29 , whereas the remaining patients had various respiratory disorders.
30 on and associated higher incidences of lower respiratory disorders.
31 ie the symptoms of asthma and other allergic respiratory disorders.
32 ity previously associated with sleep-related respiratory disorders.
33 ally used to treat human diseases, including respiratory disorders.
34 ed by bacterial biofilms in numerous chronic respiratory disorders.
35 ; OR, 2.40; 95% CI, 1.50-3.84), any neonatal respiratory disorder (2.8% vs 2.0%; OR, 1.42; 95% CI, 1.
36 dyspnoea and syncope (1368 [6%] deaths), and respiratory disorders (2662 [12%] deaths), mainly pneumo
37 wo groups, with the most common events being respiratory disorders (31 [62%] of 50 patients given pla
38 cific chest pain (1131 patients [42.2%]) and respiratory disorders (476 patients [17.7%]); cardiovasc
39 % of patients required hospitalization for a respiratory disorder and 21% died.
40  approved for the management of allergic and respiratory disorders and biologics currently in develop
41  for many diseases, including cancer, common respiratory disorders and cardiovascular diseases.
42 ere identified, including cardiovascular and respiratory disorders and diabetes.
43 atory behaviors can track the progression of respiratory disorders and diseases, including chronic re
44 ate the wider use of surfactant treatment of respiratory disorders and diseases.
45 piratory behaviors, often required to assess respiratory disorders and diseases.
46 hat deal with environmental and occupational respiratory disorders and novel approaches to their trea
47 adenocarcinoma, pulmonary haemorrhage, and a respiratory disorder), and four in the abiraterone aceta
48  of treatments, monitor the evolution of the respiratory disorder, and help the weaning process.
49 human respiratory diseases, exacerbate other respiratory disorders, and are associated with extrapulm
50 nal, kidney, mental health, musculoskeletal, respiratory disorders, and fatigue.
51 tunted growth and metabolic, infectious, and respiratory disorders, and have likely been pervasive in
52 teremia, very low birth weight, prematurity, respiratory disorders, and ROP.
53 l conditions-including thyroid, cardiac, and respiratory disorders, and substance intoxication and wi
54 n clinical practice have emerged for various respiratory disorders, and such an approach could also b
55 omorbid conditions, including neurologic and respiratory disorders; and device use, including gastros
56                                              Respiratory disorders are associated with occupational a
57  limited evidence that patients with chronic respiratory disorders are at lower risk of being infecte
58                                  Allergy and respiratory disorders are common in young athletic indiv
59 clude that the time trends of HIV-associated respiratory disorders are determined by HIV disease stag
60                                   Infectious respiratory disorders are important causes of childhood
61                                      Chronic respiratory disorders are important contributors to the
62 une responses is emphasized by the different respiratory disorders associated with abnormalities in B
63 s found for patients with only chronic lower respiratory disorders (asthma/chronic obstructive pulmon
64                                  Asthma is a respiratory disorder characterized by airway hyperreacti
65                          Asthma is a complex respiratory disorder characterized by marked heterogenei
66                           Asthma is a common respiratory disorder characterized by recurrent episodes
67 etic condition; syndromic condition; chronic respiratory disorder; chronic neurologic condition; medi
68 ling of which is essential for understanding respiratory disorders, congenital defects in human neona
69 EBC-SURE platform as a point-of-care aid for respiratory disorder diagnosis.
70 berculosis are at risk of developing chronic respiratory disorders due to residual lung damage.
71                  Severe hypercapnia, seen in respiratory disorders (eg, asthma or bronchitis, chronic
72 easonable to hold palytoxins responsible for respiratory disorders following inhalation.
73 quired cardiac disease, pneumonia, and other respiratory disorders, having never been discharged from
74 contribute to age-related disorders, such as respiratory disorders, heart disease, metabolic disorder
75 poxia, chemoreflex sensitization may lead to respiratory disorders, impacting quality of life.
76 eported for the first time is an avian-style respiratory disorder in a non-avian dinosaur.
77 gin, airsacculitis is an extremely prevalent respiratory disorder in birds today.
78 examined trends in the incidence of specific respiratory disorders in a multicenter cohort with progr
79 esence of several predefined upper and lower respiratory disorders in cases and controls.
80 rch proposes a set of sequential allergy and respiratory disorders in early childhood contributes eno
81 und only in mycobacterial species that cause respiratory disorders in humans.
82 s and anxiety during gestation are linked to respiratory disorders in newborns; however, the mechanis
83 trategy for alleviating the life threatening respiratory disorders in RTT.
84 table to the much lower rate of death due to respiratory disorders in the clozapine group.
85 eloping efficient therapy targets for severe respiratory disorders in the future.
86 ion between GERD and several upper and lower respiratory disorders in these children.
87 vata pose an emerging health threat, causing respiratory disorders in various coastal regions.
88                                          The respiratory disorders, in particular worsening of COPD,
89 ction is implicated in several developmental respiratory disorders including Congenital Central Hyper
90                   Patients known to have any respiratory disorder (including OSA) were excluded.
91  relevance for treatment of various neonatal respiratory disorders, including alveolar capillary dysp
92 ties are frequently present in patients with respiratory disorders, including chronic obstructive pul
93 nt therapy has been studied for use in other respiratory disorders, including meconium aspiration syn
94 nomic consequences of reduced work capacity; respiratory disorders, including those exacerbated by ai
95 ic obstructive pulmonary disease (COPD) is a respiratory disorder involving abnormalities of lung par
96  Pasteurella haemolytica results in an acute respiratory disorder known as pneumonic pasteurellosis.
97                   Allergic asthma, a chronic respiratory disorder marked by inflammation and recurren
98 occurs in stages; thus, effects on postnatal respiratory disorders may differ based on timing of expo
99 urther progress in the treatment of neonatal respiratory disorders may include the development of "de
100 rbidity (SLM); cardiovascular disease (CVD); respiratory disorders; neoplasms; alcohol-intoxication;
101                  Death within 90 days due to respiratory disorders occurred in 22 patients (11%) in t
102 : Primary ciliary dyskinesia (PCD) is a rare respiratory disorder of motile cilia caused by pathogeni
103 erinatal infections, candidemia, bacteremia, respiratory disorders, or ROP.
104                                              Respiratory disorders, particularly worsening of COPD, w
105 phthalmitis population included prematurity, respiratory disorders, perinatal infections, and retinop
106     Altered ENaC function is associated with respiratory disorders, pseudohypoaldosteronism type 1, a
107  embryos and individuals with the congenital respiratory disorder reduced generation of multiple moti
108                To determine if sleep-related respiratory disorder reflects cardiovascular derangement
109 missions of homeless people were for trauma, respiratory disorders, skin disorders, and infectious di
110 tic value in resensitizing steroid action in respiratory disorders such as asthma.
111 eutics for treating symptoms associated with respiratory disorders such as chronic obstructive pulmon
112 rly development on lung function and chronic respiratory disorders, such as asthma and related allerg
113   Studies have documented a role for SAgs in respiratory disorders, such as nasal polyps, chronic obs
114 ers, and cardiometabolic disorders, but more respiratory disorders, than did public program alumni.
115 ans and has potential implications for other respiratory disorders that are characterized by impaired
116  into new clinical indications, ranging from respiratory disorders through neurological and psychiatr
117 ysiology, from cardiovascular, metabolic and respiratory disorders to neurodegeneration and cancer.
118                              Conversely, the respiratory disorder was recapitulated by blocking GABAe
119 ction bronchiectasis associated with another respiratory disorder were excluded.
120                            The most frequent respiratory disorders were upper respiratory tract infec
121 bilitating and performance-limiting allergic respiratory disorder which affects 14% of horses in the

 
Page Top